Winning Health Technology Group Co., Ltd.

SZSE:300253 Stock Report

Market Cap: CN¥11.4b

Winning Health Technology Group Future Growth

Future criteria checks 4/6

Winning Health Technology Group is forecast to grow earnings and revenue by 31.8% and 17.6% per annum respectively. EPS is expected to grow by 31.9% per annum. Return on equity is forecast to be 10.7% in 3 years.

Key information

31.8%

Earnings growth rate

31.9%

EPS growth rate

Healthcare Services earnings growth26.1%
Revenue growth rate17.6%
Future return on equity10.7%
Analyst coverage

Good

Last updated02 Aug 2024

Recent future growth updates

Recent updates

Winning Health Technology Group (SZSE:300253) May Have Issues Allocating Its Capital

Aug 22
Winning Health Technology Group (SZSE:300253) May Have Issues Allocating Its Capital

These 4 Measures Indicate That Winning Health Technology Group (SZSE:300253) Is Using Debt Reasonably Well

Jul 03
These 4 Measures Indicate That Winning Health Technology Group (SZSE:300253) Is Using Debt Reasonably Well

Impressive Earnings May Not Tell The Whole Story For Winning Health Technology Group (SZSE:300253)

May 03
Impressive Earnings May Not Tell The Whole Story For Winning Health Technology Group (SZSE:300253)

Is Winning Health Technology Group (SZSE:300253) A Risky Investment?

Mar 19
Is Winning Health Technology Group (SZSE:300253) A Risky Investment?

Winning Health Technology Group Co., Ltd. (SZSE:300253) Held Back By Insufficient Growth Even After Shares Climb 25%

Mar 01
Winning Health Technology Group Co., Ltd. (SZSE:300253) Held Back By Insufficient Growth Even After Shares Climb 25%

Returns On Capital At Winning Health Technology Group (SZSE:300253) Paint A Concerning Picture

Feb 28
Returns On Capital At Winning Health Technology Group (SZSE:300253) Paint A Concerning Picture

Earnings and Revenue Growth Forecasts

SZSE:300253 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20264,994906N/A6948
12/31/20254,401708N/A5399
12/31/20243,660560N/A6279
6/30/20243,19537261385N/A
3/31/20243,209438-134168N/A
12/31/20233,163358-129185N/A
9/30/20233,123121-25382N/A
6/30/20233,18958-29624N/A
3/31/20233,09713-234107N/A
1/1/20233,093109-223100N/A
9/30/20222,85825854379N/A
6/30/20222,822333143461N/A
3/31/20222,851396171468N/A
1/1/20222,75037882368N/A
9/30/20212,658547106332N/A
6/30/20212,498528112312N/A
3/31/20212,333494212406N/A
12/31/20202,267491203390N/A
9/30/20202,08232981270N/A
6/30/20202,032311-4213N/A
3/31/20201,93935313213N/A
12/31/20191,90839842233N/A
9/30/20191,712384-61117N/A
6/30/20191,56134730194N/A
3/31/20191,480320-6161N/A
12/31/20181,439303-43124N/A
9/30/20181,439288-9391N/A
6/30/20181,330259-13627N/A
3/31/20181,242243N/A-22N/A
12/31/20171,204229N/A80N/A
9/30/20171,059193N/A-57N/A
6/30/20171,011184N/A-26N/A
3/31/2017987523N/A121N/A
12/31/2016954519N/A140N/A
9/30/2016901522N/A158N/A
6/30/2016852517N/A101N/A
3/31/2016791158N/A26N/A
12/31/2015753153N/A79N/A
9/30/2015647142N/A-48N/A
6/30/2015607142N/A8N/A
3/31/2015536127N/A22N/A
12/31/2014491121N/A43N/A
9/30/2014402100N/A62N/A
6/30/201437491N/A41N/A
3/31/201435884N/A47N/A
12/31/201334981N/A50N/A
9/30/201332568N/A50N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 300253's forecast earnings growth (31.8% per year) is above the savings rate (2.9%).

Earnings vs Market: 300253's earnings (31.8% per year) are forecast to grow faster than the CN market (16.8% per year).

High Growth Earnings: 300253's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 300253's revenue (17.6% per year) is forecast to grow faster than the CN market (10.4% per year).

High Growth Revenue: 300253's revenue (17.6% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 300253's Return on Equity is forecast to be low in 3 years time (10.7%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y